A new Aenova: medical business plans growth
German healthcare group Aenova is seeking consent from existing lenders to take over pharmaceutical firm Haupt Pharma. The acquisition forms part of plans to expand Aenova’s market share, as laid out by the company's private equity owner, BC Partners.
“In addition to continued organic growth, we are also planning further acquisitions to broaden the company’s range and to additionally enhance its competitive position in the international markets,” Stefan Zuschke, a managing partner at BC Partners, said in August 2012 of Aenova’s expansion strategy.
The €260m takeover will
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: firstname.lastname@example.org or find out more online here.